Mechanism of hepatotoxicity of first-line tyrosine kinase inhibitors: Gefitinib and afatinib
Yao Zhang, Yang Cai, Shiru Zhang, Chong-Yong Li, Lingling Jiang, Pin Wei, Ming‐Fang He
Topics & Concepts
GefitinibAfatinibCancer researchPharmacologyTyrosine-kinase inhibitorZebrafishBiologyEpidermal growth factor receptorMedicineInternal medicineCancerBiochemistryGeneLung Cancer Treatments and MutationsChronic Myeloid Leukemia TreatmentsFibroblast Growth Factor Research